title: Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease.
abstract: Functional differentiation of chromatin structure is essential for the control of gene expression, nuclear architecture, and chromosome stability. Compelling evidence indicates that alterations in chromatin remodeling proteins play an important role in the pathogenesis of human disease. Among these, α-thalassemia mental retardation X-linked protein (ATRX) has recently emerged as a critical factor involved in heterochromatin formation at mammalian centromeres and telomeres as well as facultative heterochromatin on the murine inactive X chromosome. Mutations in human ATRX result in an X-linked neurodevelopmental condition with various degrees of gonadal dysgenesis (ATRX syndrome). Patients with ATRX syndrome may exhibit skewed X chromosome inactivation (XCI) patterns, and ATRX-deficient mice exhibit abnormal imprinted XCI in the trophoblast cell line. Non-random or skewed XCI can potentially affect both the onset and severity of X-linked disease. Notably, failure to establish epigenetic modifications associated with the inactive X chromosome (Xi) results in several conditions that exhibit genomic and chromosome instability such as fragile X syndrome as well as cancer development. Insight into the molecular mechanisms of ATRX function and its interacting partners in different tissues will no doubt contribute to our understanding of the pathogenesis of ATRX syndrome as well as the epigenetic origins of aneuploidy. In turn, this knowledge will be essential for the identification of novel drug targets and diagnostic tools for cancer progression as well as the therapeutic management of global epigenetic changes commonly associated with malignant neoplastic transformation.
authors.affiliation: Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA. rfuente@uga.edu
authors.forename: Rabindranath
authors.initials: R
authors.lastname: De La Fuente
authors.forename: Claudia
authors.initials: C
authors.lastname: Baumann
authors.forename: Maria M
authors.initials: MM
authors.lastname: Viveiros
mesh_terms: D000818:Animals; D002843:Chromatin / Q000737:chemistry* / Q000378:metabolism*; D042002:Chromatin Assembly and Disassembly; D043171:Chromosomal Instability; D004265:DNA Helicases / Q000502:physiology*; D018450:Disease Progression; D044127:Epigenesis, Genetic; D005260:Female; D005600:Fragile X Syndrome / Q000378:metabolism / Q000503:physiopathology; D040181:Genetic Diseases, X-Linked / Q000378:metabolism* / Q000503:physiopathology; D006570:Heterochromatin / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D008297:Male; D038901:X-Linked Intellectual Disability / Q000378:metabolism / Q000503:physiopathology; D009687:Nuclear Proteins / Q000502:physiology*; D049951:X Chromosome Inactivation; D000075924:X-linked Nuclear Protein; D017085:alpha-Thalassemia / Q000378:metabolism / Q000503:physiopathology
chemical_list: D002843:Chromatin; D006570:Heterochromatin; D009687:Nuclear Proteins; D004265:DNA Helicases; C092332:ATRX protein, human; D000075924:X-linked Nuclear Protein